A double-blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients
- PMID: 8447241
- DOI: 10.1111/j.1600-0447.1993.tb03345.x
A double-blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients
Abstract
A randomized, double-blind, parallel-group, 6-week study was undertaken to compare the efficacy and tolerability of once or twice daily administration of the selective serotonin reuptake inhibitors paroxetine and fluoxetine. After a 1-week placebo wash-out, patients suffering from DSM-III major depression and with a score of 18 or more on the 21-item Hamilton Rating Scale for Depression (HRSD) received either paroxetine or fluoxetine. The patients were assessed for efficacy using the HRSD, Montgomery-Asberg Depression Rating Scale and Clinical Global Impression; for tolerability, adverse events were elicited by the use of a non-leading question and a side effects checklist. The groups of patients were comparable on entry to the study. One hundred patients were recruited into the study, of whom 78 were evaluable for the efficacy analysis. Paroxetine and fluoxetine showed comparable efficacy at the end of the 6-week treatment period, but a statistically significant difference in the number of responders at week 3 in favour of paroxetine was observed. This could suggest an earlier onset of action with paroxetine. Also, associated anxiety symptoms were significantly reduced on paroxetine compared with fluoxetine at week 3. Patients on paroxetine reported fewer adverse events than those on fluoxetine. The most commonly reported adverse events were nausea and vomiting in both groups.
Similar articles
-
[Paroxetine in the treatment of depression in geriatric patients--a double-blind comparative study with fluoxetine].Fortschr Neurol Psychiatr. 1994 Sep;62 Suppl 1:16-8. Fortschr Neurol Psychiatr. 1994. PMID: 7959520 Clinical Trial. German.
-
A double-blind, randomized, fluoxetine-controlled, multicenter study of paroxetine in the treatment of depression.J Clin Psychopharmacol. 1993 Dec;13(6 Suppl 2):18S-22S. doi: 10.1097/00004714-199312002-00003. J Clin Psychopharmacol. 1993. PMID: 8106650 Clinical Trial.
-
Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy, cognitive and behavioural effects.Int Clin Psychopharmacol. 1994 Spring;9(1):25-9. Int Clin Psychopharmacol. 1994. PMID: 8195578 Clinical Trial.
-
Paroxetine versus placebo: a double-blind comparison in depressed patients.J Clin Psychiatry. 1992 Dec;53(12):434-8. J Clin Psychiatry. 1992. PMID: 1487471 Clinical Trial.
-
A review of the psychomotor effects of paroxetine.Int Clin Psychopharmacol. 1992 Jun;6 Suppl 4:65-7. doi: 10.1097/00004850-199206004-00012. Int Clin Psychopharmacol. 1992. PMID: 1431014 Review.
Cited by
-
Formulary restriction of selective serotonin reuptake inhibitors for depression: potential pitfalls.Pharmacoeconomics. 2001;19(10):973-82. doi: 10.2165/00019053-200119100-00001. Pharmacoeconomics. 2001. PMID: 11735668 Review.
-
Does study design influence outcome?. The effects of placebo control and treatment duration in antidepressant trials.Psychother Psychosom. 2009;78(3):172-81. doi: 10.1159/000209348. Epub 2009 Mar 24. Psychother Psychosom. 2009. PMID: 19321970 Free PMC article.
-
Fluoxetine versus other types of pharmacotherapy for depression.Cochrane Database Syst Rev. 2013 Jul 17;2013(7):CD004185. doi: 10.1002/14651858.CD004185.pub3. Cochrane Database Syst Rev. 2013. PMID: 24353997 Free PMC article.
-
Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting system.Drug Saf. 1999 Mar;20(3):277-87. doi: 10.2165/00002018-199920030-00007. Drug Saf. 1999. PMID: 10221856
-
Fluoxetine versus other types of pharmacotherapy for depression.Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004185. doi: 10.1002/14651858.CD004185.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2013 Jul 17;(7):CD004185. doi: 10.1002/14651858.CD004185.pub3. PMID: 16235353 Free PMC article. Updated.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources